Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Lindsey A Sharpe, Adam M Daily, Sarena D Horava & Nicholas A Peppas. (2014) Therapeutic applications of hydrogels in oral drug delivery. Expert Opinion on Drug Delivery 11:6, pages 901-915.
Read now
Read now
Yellela S. R. Krishnaiah & Mansoor A. Khan. (2012) Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer. Pharmaceutical Development and Technology 17:5, pages 521-540.
Read now
Read now
Renaat Kinget, Willbrord Kalala, Liesbeth Vervoort & Guy van den Mooter. (1998) Colonic Drug Targeting. Journal of Drug Targeting 6:2, pages 129-149.
Read now
Read now
J.N. Zhang, X.G. Liu, M. Zhu, F.C.K. Chiu & R.C. Li. (1998) Assessment of Presystemic Factors on the Oral Bioavailability of Rifampicin Following Multiple Dosing. Journal of Chemotherapy 10:5, pages 354-359.
Read now
Read now
Guy Van den Mooter & Renaat Kinget. (1995) Oral colon-specific drug delivery: a review. Drug Delivery 2:2, pages 81-93.
Read now
Read now
P. W. Slattum, A. E. Cato, G. M. Pollack & K. L. R. Brouwer. (1995) Age-dependent intestinal hydrolysis of valproate glucuronide in rat. Xenobiotica 25:3, pages 229-237.
Read now
Read now
Robert W. Chadwick, S. Elizabeth George & Larry D. Claxton. (1992) Role of the Gastrointestinal Mucosa and Microflora in the Bioactivation of Dietary and Environmental Mutagens or Carcinogens. Drug Metabolism Reviews 24:4, pages 425-492.
Read now
Read now
Walter G. Levine. (1991) Metabolism of AZO Dyes: Implication for Detoxication and Activation. Drug Metabolism Reviews 23:3-4, pages 253-309.
Read now
Read now
Articles from other publishers (63)
Han Hao, Zhu Li, Shi-yang Qiao, Yu Qi, Xiao-ying Xu, Jia-yi Si, Yi-hai Liu, Lei Chang, Yi-fan Shi, Biao Xu, Zhong-hai Wei & Li-na Kang. (2023) Empagliflozin ameliorates atherosclerosis via regulating the intestinal flora. Atherosclerosis 371, pages 32-40.
Crossref
Crossref
Christina Kostantini, Sumit Arora, Erik Söderlind, Jens Ceulemans, Christos Reppas & Maria Vertzoni. (2022) Usefulness of Optimized Human Fecal Material in Simulating the Bacterial Degradation of Sulindac and Sulfinpyrazone in the Lower Intestine. Molecular Pharmaceutics 19:7, pages 2542-2548.
Crossref
Crossref
Constantinos Markopoulos & Maria Vertzoni. 2022. Oral Drug Delivery for Modified Release Formulations. Oral Drug Delivery for Modified Release Formulations
305
324
.
Kangkang Ying, Bingjun Bai, Xing Gao, Yuzi Xu, Hangxiang Wang & Binbin Xie. (2021) Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Masaaki Nagano, Masatake Fujimura, Yuya Tada & Yoshiyuki Seko. (2021) Dietary Fructooligosaccharides Reduce Mercury Levels in the Brain of Mice Exposed to Methylmercury. Biological and Pharmaceutical Bulletin 44:4, pages 522-527.
Crossref
Crossref
Denish Bardoliwala, Dipesh Baradia, Jitendra Amrutiya & Ambikanandan Misra. 2021. Applications of Polymers in Drug Delivery. Applications of Polymers in Drug Delivery
187
220
.
Vijay Kumar Singh, Veena Singh & Vishal Tyagi. 2021. Colon Cancer Diagnosis and Therapy. Colon Cancer Diagnosis and Therapy
303
332
.
Naazneen Surti, Ashok Mahajan & Jitendra Amrutiya. 2019. Novel Drug Delivery Technologies. Novel Drug Delivery Technologies
151
181
.
Pruthvi C Revaiah, Rakesh Kochhar, Surinder V Rana, Neha Berry, Munish Ashat, Narendra Dhaka, Y Rami Reddy & Saroj K Sinha. (2018)
Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors
versus
proton pump inhibitors plus prokinetics
. JGH Open 2:2, pages 47-53.
Crossref
Crossref
Srushti M. Tambe & Namita D. Desai. 2018. Research Advancements in Pharmaceutical, Nutritional, and Industrial Enzymology. Research Advancements in Pharmaceutical, Nutritional, and Industrial Enzymology
71
99
.
Vijay Kothari, Chinmayi Joshi, Pooja Patel, Deepa Shahi, Charmi Mehta, Bhumika Prajapati, Sweta Patel, Dipeeka Mandaliya & Sriram Seshadri. 2018. Design of Nanostructures for Versatile Therapeutic Applications. Design of Nanostructures for Versatile Therapeutic Applications
325
377
.
H. Gelberg. 2018. Comprehensive Toxicology. Comprehensive Toxicology
139
178
.
Michael Waters & Claude HughesR. Brooks Robey. 2017. Translational Toxicology and Therapeutics: Windows of Developmental Susceptibility in Reproduction and Cancer. Translational Toxicology and Therapeutics: Windows of Developmental Susceptibility in Reproduction and Cancer
511
606
.
Sandrine P Claus, Hervé Guillou & Sandrine Ellero-Simatos. (2016) The gut microbiota: a major player in the toxicity of environmental pollutants?. npj Biofilms and Microbiomes 2:1.
Crossref
Crossref
Peter Spanogiannopoulos, Elizabeth N. Bess, Rachel N. Carmody & Peter J. Turnbaugh. (2016) The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nature Reviews Microbiology 14:5, pages 273-287.
Crossref
Crossref
Li-ping Liang, Hong-lang Chen, Shu-ming Zhao, Wen-feng Chen, Li-jun Song & Wen-chang Zhao. (2016) Preparation of Colon-specific and Synchronous Release Pellet Containing Total Alkaloids of Sophora alopecuroides. Chinese Herbal Medicines 8:1, pages 44-52.
Crossref
Crossref
Frederique Rodieux, Melanie Wilbaux, Johannes N. van den Anker & Marc Pfister. (2015) Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children. Clinical Pharmacokinetics 54:12, pages 1183-1204.
Crossref
Crossref
Seth Amidon, Jack E. Brown & Vivek S. Dave. (2015) Colon-Targeted Oral Drug Delivery Systems: Design Trends and Approaches. AAPS PharmSciTech 16:4, pages 731-741.
Crossref
Crossref
Mark Johnson, Shayne Gad & Christopher Kemper. 2015. Animal Models in Toxicology, Third Edition. Animal Models in Toxicology, Third Edition
153
283
.
Teruaki Akao, Yugi Oyanagi, Satoshi Shiotsuki, Yoko Ishii & Masakiyo Sasahara. (2015) Metabolism of Dextran Sulfate Sodium by Intestinal Bacteria in Rat Cecum Is Related to Induction of Colitis. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 38:4, pages 566-570.
Crossref
Crossref
Rajkumar Malayandi, Phani Krishna Kondamudi, P. K. Ruby & Deepika Aggarwal. (2013) Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease. Drug Delivery and Translational Research 4:2, pages 187-202.
Crossref
Crossref
Shahrul R. Sarbini, Sofia Kolida, Glenn R. Gibson & Robert A. Rastall. (2012)
In vitro
fermentation of commercial α-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects
. British Journal of Nutrition 109:11, pages 1980-1989.
Crossref
Crossref
Guoxiang Xie, Xin Li, Houkai Li & Wei Jia. (2013) Toward Personalized Nutrition: Comprehensive Phytoprofiling and Metabotyping. Journal of Proteome Research 12:4, pages 1547-1559.
Crossref
Crossref
Roberto Flores, Jianxin Shi, Mitchell H. Gail, Jacques Ravel & James J. Goedert. (2012) Assessment of the human faecal microbiota: I. Measurement and reproducibility of selected enzymatic activities. European Journal of Clinical Investigation 42:8, pages 848-854.
Crossref
Crossref
Yanli Deng, Martin Rogers, Caroline Sychterz, Kimberly Talley, Yanwen Qian, David Bershas, May Ho, Wei Shi, Emile P. Chen, Cosette Serabjit-Singh & Peter D. Gorycki. (2011) Investigations of Hydrazine Cleavage of Eltrombopag in Humans. Drug Metabolism and Disposition 39:9, pages 1747-1754.
Crossref
Crossref
Shahrul R. Sarbini, Sofia Kolida, Thierry Naeye, Alexandra Einerhand, Yoann Brison, Magali Remaud-Simeon, Pierre Monsan, Glenn R. Gibson & Robert A. Rastall. (2011)
In Vitro
Fermentation of Linear and α-1,2-Branched Dextrans by the Human Fecal Microbiota
. Applied and Environmental Microbiology 77:15, pages 5307-5315.
Crossref
Crossref
Cuneyt TaymanMaisa Rayyan & Karel Allegaert. (2011) Neonatal Pharmacology: Extensive Interindividual Variability Despite Limited Size. The Journal of Pediatric Pharmacology and Therapeutics 16:3, pages 170-184.
Crossref
Crossref
Maria Vertzoni, Anders Carlsson, Bertil Abrahamsson, Konstantinos Goumas & Christos Reppas. (2011) Degradation kinetics of metronidazole and olsalazine by bacteria in ascending colon and in feces of healthy adults. International Journal of Pharmaceutics 413:1-2, pages 81-86.
Crossref
Crossref
Mirela Nadler Milabuer, Yossi Kam & Abraham Rubinstein. 2010. Oral Controlled Release Formulation Design and Drug Delivery. Oral Controlled Release Formulation Design and Drug Delivery
225
243
.
He Wei, Fan Li-Fang, Chang Yong-Zhen, Xiang Bai, Du Qing, Bai Min, Wang Feng, Qing Min & Cao De-Ying. (2009) Pectin/Kollicoat SR30D isolated films for colonic delivery [I]: a comparison of normal and colitis-induced models to assess the efficiency of microbially triggered drug delivery. Journal of Pharmacy and Pharmacology 61:2, pages 167-176.
Crossref
Crossref
Thomas F. Burks. 2010. Comprehensive Toxicology. Comprehensive Toxicology
117
144
.
Shiuan-Woei LinWu, Cheng-Jie Syu, Yu-Lian Chen, Andrew H.-J. Wang & Fu-Chuo Peng. (2009) Characterization of Escherichia coli nitroreductase NfsB in the metabolism of nitrobenzodiazepines. Biochemical Pharmacology 78:1, pages 96-103.
Crossref
Crossref
Fan Li-Fang, He Wei, Chang Yong-Zhen, Xiang Bai, Du Qing, Wang Feng, Qin Min & Cao De-Ying. (2009) Studies of chitosan/Kollicoat SR 30D film-coated tablets for colonic drug delivery. International Journal of Pharmaceutics 375:1-2, pages 8-15.
Crossref
Crossref
PEDRO CABRALES & JOEL M. FRIEDMAN. (2007) Pegylated hemoglobins mechanisms to avoid vasoconstriction and maintain perfusion. Transfusion Alternatives in Transfusion Medicine 9:4, pages 281-293.
Crossref
Crossref
Carlos José Sousa Passos, Donna Mergler, Myriam Fillion, Mélanie Lemire, Frédéric Mertens, Jean Rémy Davée Guimarães & Aline Philibert. (2007) Epidemiologic confirmation that fruit consumption influences mercury exposure in riparian communities in the Brazilian Amazon. Environmental Research 105:2, pages 183-193.
Crossref
Crossref
Raymond Kemper, Johnnie Hayes & Matthew Bogdanffy. 2007. Principles and Methods of Toxicology, Fifth Edition. Principles and Methods of Toxicology, Fifth Edition
103
178
.
Donald G. Robertson, Michael D. Reily & Glenn H. Cantor. 2007. The Handbook of Metabonomics and Metabolomics. The Handbook of Metabonomics and Metabolomics
241
277
.
Max Bingham. 2006. Gastrointestinal Microbiology. Gastrointestinal Microbiology
155
168
.
Tina Kold Jensen, Philippe Grandjean, Esben Budtz Jørgensen, Roberta F White, Frodi Debes & Pál Weihe. (2005) Effects of breast feeding on neuropsychological development in a community with methylmercury exposure from seafood. Journal of Exposure Science & Environmental Epidemiology 15:5, pages 423-430.
Crossref
Crossref
Jeremy K. Nicholson, Elaine Holmes & Ian D. Wilson. (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nature Reviews Microbiology 3:5, pages 431-438.
Crossref
Crossref
S.Steve Yan & Jeffrey M Gilbert. (2004) Antimicrobial drug delivery in food animals and microbial food safety concerns: an overview of in vitro and in vivo factors potentially affecting the animal gut microflora. Advanced Drug Delivery Reviews 56:10, pages 1497-1521.
Crossref
Crossref
C. Gill & I. Rowland. 2003. Functional Dairy Products. Functional Dairy Products
19
53
.
Hirokazu Sakamoto, Hiroshi Yokota, Ryoko Kibe, Yoshikatu Sayama & Akira Yuasa. (2002) Excretion of bisphenol A-glucuronide into the small intestine and deconjugation in the cecum of the rat. Biochimica et Biophysica Acta (BBA) - General Subjects 1573:2, pages 171-176.
Crossref
Crossref
Kieran Tuohy, Ian Rowland & Paul Rumsby. 2002. Genetically Modified Crops. Genetically Modified Crops.
C. I. R. Gill & I. R. Rowland. (2007) Diet and cancer: assessing the risk. British Journal of Nutrition 88:S1, pages s73-s87.
Crossref
Crossref
Willi Suter, Andreas Hartmann, Franziska Poetter, Peter Sagelsdorff, Peter Hoffmann & Hans-Jörg Martus. (2002) Genotoxicity assessment of the antiepileptic drug AMP397, an Ames-positive aromatic nitro compound. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 518:2, pages 181-194.
Crossref
Crossref
Montserrat Gudiel-Urbano & Isabel Goñi. (2002) Effect of edible seaweeds (Undaria pinnatifida and Porphyra ternera) on the metabolic activities of intestinal microflora in rats. Nutrition Research 22:3, pages 323-331.
Crossref
Crossref
Linda S Boeckner, Marilynn I Schnepf & Bryan C Tungland. 2001.
1
63
.
Hans-P. Kruse, Brigitta Kleessen & Michael Blaut. (2007) Effects of inulin on faecal bifidobacteria in human subjects. British Journal of Nutrition 82:5, pages 375-382.
Crossref
Crossref
Margaretha DU TOIT, Silvia KNOPFEL, Frank A. SK^|^Ouml;WRONEK, Ingrid SPECHT, Wolfgang B^|^Ouml;CKELER & Wilhelm H. HOLZAPFEL. (1998) A Modified Continuous Flow Culture System for Studying Microbial Interactions Related to the Gastro-Intestinal Tract: Application of the Probiotic Organism Enterococcus faecium SF68. Bioscience and Microflora 17:1, pages 41-47.
Crossref
Crossref
Rudolf Fahrig & Martin Engelke. (1997) Reinvestigation of in vivo genotoxicity studies in man. I. No induction of DNA strand breaks in peripheral lymphocytes after metronidazole therapy. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 395:2-3, pages 215-221.
Crossref
Crossref
Zakia Djouzi & Claude Andlueux. (2007) Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with a human faecal flora. British Journal of Nutrition 78:2, pages 313-324.
Crossref
Crossref
RK Buddington, CH Williams, SC Chen & SA Witherly. (1996) Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. The American Journal of Clinical Nutrition 63:5, pages 709-716.
Crossref
Crossref
O. Carrette, C. Favier, C. Mizon, C. Neut, A. Cortot, J. F. Colombel & J. Mizon. (1995) Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease. Digestive Diseases and Sciences 40:12, pages 2641-2646.
Crossref
Crossref
Lars Hovgaard & Helle Brøndsted. (1995) Dextran hydrogels for colon-specific drug delivery. Journal of Controlled Release 36:1-2, pages 159-166.
Crossref
Crossref
Carl E. Cerniglia & Charles C. Somerville. 1995. Biodegradation of Nitroaromatic Compounds. Biodegradation of Nitroaromatic Compounds
99
115
.
Jerjang Chang, R.W. Chadwick, Joycelyn C. Allison, Yumiko O. Hayes, Detra L. Talley & Cari E. Autry. (2008) Microbial succession and intestinal enzyme activities in the developing rat. Journal of Applied Bacteriology 77:6, pages 709-718.
Crossref
Crossref
M. Mikov. (1994) The metabolism of drugs by the gut flora. European Journal of Drug Metabolism and Pharmacokinetics 19:3, pages 201-207.
Crossref
Crossref
Lubomír Dobiáš, Milena Černá, Pavel Rössner & Radim Šrám. (1994) Genotoxicity and carcinogenicity of metronidazole. Mutation Research/Reviews in Genetic Toxicology 317:3, pages 177-194.
Crossref
Crossref
Tsutomu Kaneko, Hiroharu Mori, Megumi Iwata & Sachiko Meguro. (1994) Growth Stimulator for Bifidobacteria Produced by Propionibacterium freudenreichii and Several Intestinal Bacteria. Journal of Dairy Science 77:2, pages 393-404.
Crossref
Crossref
P GrandjeanPJ JørgensenP Weihe. (1994) Human Milk as a Source of Methylmercury Exposure in Infants.. Environmental Health Perspectives 102:1, pages 74-77.
Crossref
Crossref
M.Abu Shamat. (1993) The role of the gastrointestinal microflora in the metabolism of drugs. International Journal of Pharmaceutics 97:1-3, pages 1-13.
Crossref
Crossref
Kenneth F. Ilett, Lisa B.G. Tee, Philip T. Reeves & Rodney F. Minchin. (1990) Mebolism of drugs and other xenobiotics in the gut lumen and wall. Pharmacology & Therapeutics 46:1, pages 67-93.
Crossref
Crossref